Saxagliptin Hydrochloride INN
Composition : Saxagliptin INN 2.5 mg & 5mg Tablet.
Indications: Saxagliptin is a dipeptidyl peptidase-4 (DPP4) inhibitor. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Dosage & Administration: The recommended dosage is 2.5 mg or 5mg once daily taken regardless of meals. Patients with renal impairment : No dosage adjustment is required for mild renal impaired Patient. 2.5 mg is taken once daily for patient with moderate or severe renal impairment, or with end-stage renal disease (ESRD) requiring hemodialysis (creatinine clearance [CrC1] <_ 50 mL/min). Saxagliptin should be administered following hemodialysis. Or, as directed by the registered physician.
Pregnency & Lactation: Pregnancy Category-B. There are no adequate and well-controlled studies in pregnant women. It is unknown whether Saxagliptin is secreted in human milk. It should be used with caution during pregnancy & Iactation only if elearly needed.
Packing: Sixtin 2.5 Tablet : 1 x 14's tablets in blister pack.
Sixtin 5 Tablet : 1 x 14's tablets in blister pack.
